Apheresis is an invasive process that involves the separation of components such as platelets, RBC, plasma, and other components from whole blood. In this procedure, the blood of a donor or a patient is passed through an apheresis machine or a blood cell separator.
Currently, The industry is highly concentrated, technical barriers and financial barriers are relatively high. The companies in the world that produce Apheresis Equipment mainly concentrate in North America and Europe, Raw materials are also concentrated in these regions. In particular, as the market leader in Apheresis Equipment, Haemonetics Corporation global market share is more than 34%, other key manufacturers include Fresenius Medical Care, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc. etc.

Market Analysis and Insights: Global Apheresis Equipment Market
The global Apheresis Equipment market is valued at US$ 212.7 million in 2019. The market size will reach US$ 310.7 million by the end of 2026, growing at a CAGR of 5.5% during 2021-2026.

Global Apheresis Equipment Scope and Market Size
Apheresis Equipment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Apheresis Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Centrifugation
Membrane Filtration

Segment by Application
Platelets
RBC
Plasma
Others

By Company
Haemonetics Corporation
Fresenius Medical Care
Terumo BCT, Inc.
Asahi Kasei Medical Co., Ltd.
Kawasumi Laboratories Inc.
B. Braun Melsungen AG
Therakos
NIKKISO
Macopharma
Medica SPA

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia